Money Concepts Capital Corp Amphastar Pharmaceuticals, Inc. Transaction History

Money Concepts Capital Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 27, 2022	BUY	$27.56 - $37.75 $12,512 - $17,138	454 Added 4.71%	10,099 $284,000
Q2 2022 Jul 18, 2022	BUY	$29.79 - $42.29 $16,175 - $22,963	543 Added 5.97%	9,645 $341,000
Q1 2022 May 13, 2022	SELL	$22.96 - $36.45 $12,122 - $19,245	-528 Reduced 5.48%	9,102 $327,000
Q4 2021 Feb 14, 2022	BUY	$18.14 - $23.29 $174,688 - $224,282	9,630 New	9,630 $224,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.78B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

Stay updated on Money Concepts Capital Corp with notifications on news.